NOVO NORDISK NORWAY AS

NOVO NORDISK NORWAY AS is registered as a limited company in Oslo, Oslo with organisation number 918229353. The business is classified under wholesale of pharmaceutical and medical goods (NACE 46.460). The company was incorporated in 1965 and has 87 registered employees. Registered share capital is NOK 250,000. The company's stated purpose is: “Omsetning av legemidler fremstilt av Novo Nordisk AS, København.”. The most recent filed accounts, for the 2024 financial year, show NOK 3.0bn in revenue and NOK 104.5m in operating profit.

Key figures · 2024

Revenue

NOK 3.0bn

Operating profit

NOK 104.5m

Equity

NOK 3.9m

Est. value

NOK 415.3m

Financial health · 2024

Liquidity

1.00

Satisfactory

Current assets ÷ current liabilities

Profitability

–

Not available

Return on total assets

Solidity

0.5%

Not satisfactory

Equity as a share of total capital

Who owns NOVO NORDISK NORWAY AS?

NOVO NORDISK REGION EUROPE AS

100.0%

NOVO NORDISK NORWAY AS

NOK 3.0bn rev. · NOK 104.5m profit

NOVO NORDISK NORWAY AS has 1 registered shareholder:

• NOVO NORDISK REGION EUROPE AS 100.0%

All shareholders and roles →

Group structure

NOVO NORDISK NORWAY AS er morselskap for 1 datterselskap:

• NOVO NORDISK NORWAY AS 100%

Frequently asked questions about NOVO NORDISK NORWAY AS

Who owns NOVO NORDISK NORWAY AS?

NOVO NORDISK REGION EUROPE AS is the largest registered owner, with 100.0%.

What is the revenue of NOVO NORDISK NORWAY AS?

NOVO NORDISK NORWAY AS had revenue of NOK 3.0bn in 2024.

Who is the general manager of NOVO NORDISK NORWAY AS?

Nina Therese Hovland is registered as general manager of NOVO NORDISK NORWAY AS.

Where is NOVO NORDISK NORWAY AS based?

NOVO NORDISK NORWAY AS has its business address in Oslo.

Source: Biztrac.no · Data from the Brønnøysund Register Centre and the Norwegian Tax Administration · Last updated 15.06.2026.